Infectious diseases in the developing world - Preventative and Diagnostic advances (TechVision)

Impact and assessment of novel diagnostic techniques to detect key infectious diseases

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

Infectious diseases that are caused by major pathogenic microorganisms such as viruses and bacteria pose severe public health challenges for individual governments. the International Health Regulations set up by the World Health Organization aims to cut down the risk of transfer of such infections across borders and limit the spread of disease. The research study on infectious diseases covers a range of diseases such as HIV, Ebola, Tuberculosis, Dengue, HPV, Malaria and HCV, which plague the developing regions currently. Additionally, the aim of this research service is to understand the existing diagnostics in the detection of these diseases as well as the diagnostic and preventative advances from key innovators that focus on regions of Africa, Asia and Latin America severely affected by infectious diseases. Apart from mapping the drivers and challenges that hold key to success of the diagnostics market for infectious diseases, the research study also details the healthcare structure, access and technology adoption in these three regions. Finally, the last three sections present the funding scenario, opportunity evaluation and IP landscape of key participants in the study.

Table of Contents

Executive SummaryResearch Process MethodologyResearch Methodology (continued)Key FindingsSneak PreviewOverviewHuman Immunodeficiency Virus (HIV)Hepatitis C Virus (HCV)Human Papillomavirus (HPV)TuberculosisEbolaMalariaDengueTechnology AssessmentTuberculosisTuberculosisTuberculosisTuberculosisTuberculosisHIVHIVHIVHCVHCVHCVEbolaEbolaEbolaEbolaEbolaDengueDengueDengueDengueMalariaMalariaMalariaHPVHPVHPVHPVPreventative advancesImpact Assessment and AnalysisImpact Mapping of Drivers and ChallengesMarket Impact—Drivers ExplainedMarket Impact—Challenges ExplainedDiffusion of InnovationsTechnology AdoptionTechnology AdoptionTechnology AdoptionFunding ScenarioFunding scenario Funding scenario Funding scenarioFunding scenario Funding scenarioFunding scenarioOpportunity EvaluationAssessment of Partnerships Assessment of Partnerships (continued)Assessment of Partnerships (continued)Assessment of Partnerships (continued)Mergers and AcquisitionsMergers & Acquisitions (continued)IP LandscapeHIV DiagnosisHPV DiagnosisHCV DiagnosisEbola DiagnosisTuberculosis DiagnosisMalaria DiagnosisDengue DiagnosisInfluenza DiagnosisKey Patents and ContactsGlobal PatentsGlobal Patents (continued)Global Patents (continued)Key contactsLegal DisclaimerThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition: Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy




Keyword1
infectious diseases therapeutics
Keyword2
therapeutic area
Keyword3
infectious diseases therapeutics

Related Research

Release Date : 21-Nov-17

Region : Asia Pacific

Release Date : 15-Nov-17

Region : Asia Pacific

Release Date : 15-Nov-17

Region : Asia Pacific

Release Date : 14-Nov-17

Region : Asia Pacific

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.